The Actavis Group maintains modern development and manufacturing facilities in Europe, the US and Asia.

These plants produce a range of medicines in various formulations, including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids.

Research & Development sites: Denmark, Iceland, India, Malta, North America, Romania, Turkey, the United Kingdom.

Manufacturing sites: Bulgaria, China, Iceland, India*, Indonesia, Italy, Malta, North America, Norway**, Romania, Serbia, Turkey, the United Kingdom.

 * Contract manufacturing
** Manufacturing plant for plasters, athletic tape, and adhesive coating

Sales & Marketing offices
The introduction of new products and markets remains a constant goal. A growing sales network continues to increase access to Actavis products. 

• US Sales: North America
• WEMEA Sales: Africa, Austria, Germany, the Middle East, the Netherlands, Nordic region, Portugal, Switzerland, the United Kingdom
• CEEA Sales: Asia-Pacific Region, Australia, China, the Balkans, the Baltics, Bulgaria, the Commonwelth of Independent States, the Czech Republic, Hungary, Indonesia, Malta, Mongolia, Poland, Romania, Russia, Slovenia, Slovakia, Turkey, the Ukraine
• Third-party Sales: Germany, Iceland, the United Kingdom